Compare Citius Pharmaceuticals Inc (CTXR) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Standard Lithium Ltd — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Standard Lithium Ltd trades at $2.44 (market cap $604.50M). The key difference: Standard Lithium Ltd is far larger — about 30.2× Citius Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| CTXR | SLI | |
|---|---|---|
Market Cap | $20.01M | $604.50M |
Sector | Health | Basic Materials |
52-Week High | $1.82 | $5.65 |
52-Week Low | $0.48 | $1.93 |
Enterprise Value | $16.23M | $467.42M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
